Nifty falls over Samvat as pharma and metals outperform
In short
Nifty ended lower over the Samvat period, even as pharma and metal stocks did well. CNBC TV18 said several heavy stocks fell sharply during the year.
What the reporting says
Nifty ended lower over the Samvat period, while pharma and metal stocks delivered strong gains, according to a CNBC TV18 Market summary. The report says several heavyweight stocks also saw sharp declines, making the year challenging for Indian equities overall. The move shows a mixed market, with sector winners offset by weakness in large caps.
Why it matters
Nifty ended lower across the Samvat period, while pharma and metal stocks were among the strongest performers, based on a CNBC TV18 Market summary. The same note says several heavyweight stocks suffered sharp declines, which hurt the broader market picture. The story is about relative sector strength versus weakness in large-cap names rather than a single event or corporate announcement.